“We are the first generation on either side of our families to experience this level of success.”
GLP-1 Feud Ends: NOVO, HIMS Join Forces (Again) To Sell Obesity Drugs
GLP-1 Feud Ends: NOVO, HIMS Join Forces (Again) To Sell Obesity Drugs The epic, months-long GLP-1 feud between Novo Nordisk and telehealth…